Rumford, RI, United States of America

A Raymond Frackelton, Jr



Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: A Raymond Frackelton, Jr.: Innovator in Cancer Prognosis

Introduction

A Raymond Frackelton, Jr. is a notable inventor based in Rumford, Rhode Island, who has made significant contributions to the field of medical research, particularly in cancer prognosis. With a total of three patents to his name, his work focuses on innovative methods for predicting cancer recurrence and aggressiveness using specific proteins.

Latest Patents

Frackelton's latest patents include revolutionary methods for prognosing the recurrence of gastrointestinal and other cancers through tyrosine phosphorylated Shc (PY-Shc) and/or p66-Shc proteins. This invention not only provides a means to evaluate the recurrence risks associated with these cancers but also introduces the utility of Shc protein-related methods for assessing breast, prostate, and ovarian cancers. Furthermore, these inventions offer a technique for determining the aggressiveness of tumors based on the quantification of p66-Shc and phosphorylated Shc, along with the potential for identifying whether tumors can be effectively treated using tyrosine kinase inhibitors. Alongside the methods, antibodies and kits are also developed for the practical implementation of these innovations.

Career Highlights

Throughout his career, Frackelton has held positions at prominent research institutions such as the Salk Institute for Biological Studies and Roger Williams General Hospital. These environments have enabled him to pursue groundbreaking research while advancing his inventions aimed at improving cancer care.

Collaborations

Frackelton has collaborated with distinguished colleagues, including Paul Calabresi and Julie G. Beitz. Their combined expertise and insights have played a crucial role in furthering his research initiatives and enhancing the impact of his inventions in the medical community.

Conclusion

A Raymond Frackelton, Jr. stands out as a remarkable inventor whose work has the potential to transform cancer prognosis and treatment. His innovative approaches and collaborations contribute significantly to advancing medical research and improving outcomes for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…